Table 1. ABRO1 levels in tumour samples.
Tumour samples |
Samples with decreased ABRO1 expression |
|
---|---|---|
Ratio of decreased samples | Average tumour/adjacent in decreased samples* | |
Hepatic cellular cancer | 256/310 (83%) | 0.39±0.21 |
Thyroid cellular cancer | 21/31 (68%) | 0.22±0.13 |
Breast cellular cancer | 43/61 (70%) | 0.61±0.17 |
Renal cellular cancer | 97/136 (71%) | 0.53±0.19 |
*Data of tumour/adjacent are shown as mean±s.d. (n=samples with deregulated ABRO1 expression).